STEPHEN DAVIS Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
Get free email notifications about insider trading for STEPHEN DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN DAVIS. STEPHEN DAVIS is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Exec. VP, Chief Oper. Officer in NEUROGEN CORP ($NRGN) and President in NEUROGEN CORP ($NRGN) and President, CEO in NEUROGEN CORP ($NRGN) and Sr VP, Chief Business Officer in NEUROGEN CORP ($NRGN) and Sr VP, Chief Operating Officer in NEUROGEN CORP ($NRGN) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and INTERIM CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and PRESIDENT AND CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
STEPHEN DAVIS in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN DAVIS: Director
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN DAVIS in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, BLCM, HRTX, NRGN, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 25.00 | 3,000 | 75,000 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 23.95 | 4,000 | 95,800 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 20.60 | 3,000 | 61,800 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 11.35 | 3,000 | 34,050 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 10.10 | 3,000 | 30,300 | 0 |
Page: 1